phase ii trial of neoadjuvant bevacizumab modified folfox7 in rectal cancer
Published 3 years ago • 49 plays • Length 4:03Download video MP4
Download video MP3
Similar videos
-
0:46
prospect: neoadjuvant crt vs folfox in locally advanced rectal cancer
-
3:46
overview of rapido trial in rectal cancer and foxtrot trial in colon cancer
-
2:48
total neoadjuvant therapy pembrolizumab in locally-advanced rectal cancer
-
1:34
neoadjuvant therapy and organ preservation in rectal cancer
-
3:00
foxtrot: neoadjuvant folfox chemotherapy in colorectal cancer
-
2:04
a phase ii trial investigating neoadjuvant abiraterone and cabazitaxel in high-risk prostate cancer
-
3:26
elucidating the optimal total neoadjuvant therapy in rectal cancer
-
1:19
pemrec: neo-adjuvant pembrolizumab and rt in rectal cancer
-
3:00
neoadjuvant and adjuvant chemotherapy with tme in t3 rectal cancer
-
14:38
rectal cancer & total neoadjuvant therapy - rapido trial, polish 2 and opra trial, prodige 23 trial
-
1:07
the benefits and pitfalls of total neoadjuvant therapy in rectal cancer
-
8:34
neoadjuvant chemo with mfolfirinox shows survival benefit in locally advanced rectal cancer
-
16:36
which neoadjuvant treatment in rectal cancer?
-
2:03
preoperative management of operable ct3 cn1 luminal breast cancer: upfront neoadjuvant chemotherapy
-
1:35
what is neoadjuvant therapy?
-
23:05
total neoadjuvant therapy in rectal cancer in the community setting | 2022 evolution conference
-
3:35
adding chemotherapy to immunotherapy in metastatic crc
-
15:42
role of targeted agents in rectal cancer
-
17:08
tnt in rectal cancer speaker: dr. mervat mahrous